X

Drug Profile

TM 30339

Alternative Names: TM30339

Latest Information Update: 23 Sep 2015

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator 7TM Pharma
Class Obesity therapies; Peptides
Mechanism of Action Neuropeptide Y4 receptor agonists

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity Yes

Highest Development Phases

Discontinued Gastrointestinal disorders; Obesity

Most Recent Events

23 Apr 2010 Pharmacodynamics data from a Preclinical trial in Gastrointestinal disorders released by 7TM Pharma
02 Sep 2008 Phase-I/II clinical trials in Obesity in USA (Parenteral)
12 Mar 2007 Preclinical data added to the Obesity pharmacodynamics section

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com